About us
The team
-
Prof Kausik K. Ray
Personal details
Prof Kausik K. Ray Head of ICCP, Chair and Professor, Department of Primary Care and Public HealthProfessor Ray's research interests focus on the prevention of cardiovascular disease with a special interest in lipids and diabetes. He has investigated the early benefits of statin therapy, the advantages of more/less intensive glycaemic control, and the risks/benefits of aspirin therapy. These have influenced AHA/ACC and ESC guidelines. His work on statins and diabetes risk led to a global label change for statins by the FDA and EMEA. He continues to investigate the role of lipids, lipoproteins, diabetes, inflammation and thrombosis and coronary events. Currently, he leads the EAS Familial Hypercholesterolaemia (FH) Studies collaboration, is the Senior Principle Investigator (PI) for the TOGETHER study and is the primary investigator for all other projects within ICCP.
-
Dr Antonio Vallejo-Vaz
Dr Vallejo-Vaz is involved in different epidemiological research projects and evidence-synthesis studies related to cardiovascular risk factors and diseases. He is the main coordinator for the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), an international initiative aiming to generate large scale robust data on how Familial Hypercholesterolaemia (FH) is detected and managed and the clinical consequences of the current practice on outcomes.
-
Dr Alexander Lyons
Dr. Lyons is the Research Associate Project Manager on the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Global Clinical Registry, based at the EAS FHSC Coordinator Centre.
-
Mr Christophe Stevens
Christophe is an Information Technology professional who likes to take part in projects at the crossroads between Medicine, Biostatistics, Epidemiology and technology. As the software developer of the EAS Familial Hypercholesterolemia Studies Collaboration (FHSC), Christophe’s tasks consist in designing, programming and managing various data collection Web Apps and Data Warehouses.
-
Dr Toshiyuki Nishikido
I am a postdoctoral fellow of preventive cardiovascular medicine. In the last several years, I have been working as a cardiologist with a sub-specialty interest in cardiac catheter intervention for cardiovascular disease in Japan. My research interests are cardiovascular risk factors such as dyslipidaemia and diabetes. I work on different projects related with cardiovascular risks and drug treatments.
-
Ms Kanika Dharmayat
I am a research assistant in the Imperial Centre for Cardiovascular Disease Prevention working with Professor Ray on the TOGETHER study. The project aim is to use Big Data and EHRs to understand the burden of cardiovascular disease and its risk factors in different population groups to inform development and tailoring of risk prediction tools.
-
Dr Ailsa McKay
-
Ms Maria Woringer
Ms. Maria Woringer is a research experienced project manager and self-funded PhD student examining the impact of preventive programmes on risk awareness and self-management of cardiovascular disease (CVD). Ms. Woringer is implementing a 21 month study funded by the American Heart Association that she co-designed, to examine the impact of a web application on patients’ self-management of cholesterol.
-
Dr Osman Najam
Personal details
Dr Osman NajamHonorary Clinical Research FellowDr. Najam is a Specialist Registrar in Cardiology and obtained an Academic Clinical Fellowship in Cardiology in London which gave him his first research exposure to Preventative Cardiology and Epidemiology, with Professor Kausik Ray. He joined the ICCP to develop his academic interests and is currently doing a PhD to continue to explore these areas of research interest.
-
Dr Rao Kondapally Seshasai
Personal details
Dr Rao Kondapally SeshasaiHonorary Clinical Lecturer in Public HealthDr Seshasai is currently the co-investigator for TOGETHER study, which is aimed at collating routinely collected data on individuals attending the NHS Health Checks programme in South London, and ultimately using this information to improve CVD risk prediction among diverse populations.
Our collaborators
European Atherosclerosis Society
European Atherosclerosis Society
Amsterdam Medical Centre
Amsterdam Medical Centre
Imperial Clinical Trials Unit
Imperial Clinical Trials Unit
Harvard Clinical Research Institute
Harvard Clinical Research Institute
University of Leicester
University of Leicester
Acknowledgements
ICCP wishes to acknowledge the generosity of its funding partners (including the National Institute for Health Research, Pfizer, Regeneron, Amgen, Sanofi, and MSD) for supporting its staff and its diverse portfolio of research.